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Attention: We are anticipating hosting an Immunization training
around the first of the year 2021.

Flu season is around the corner.
As a refresher, the following youtube sites are available:

I: Technique
o APhA Injection Technique https://www.youtube.com/watch?v=1H7LnK0CpOY
o Handling Syringe and Needle https://www.youtube.com/watch?v=3yjsV4akL8A
o Reading Syringes https://www.youtube.com/watch?v=b4Y2qE4ZgvE

II: Safety Syringes and Sharps
o
o
o
o

Vanishing point syringes https://www.youtube.com/watch?v=BikjXikTUEw
BD eclipse safety needles https://www.youtube.com/watch?v=OgyrAf5dpZc
Terumo SurGuard https://www.youtube.com/watch?v=xHOt3MZoLuU
Safely Handling Sharps https://www.youtube.com/watch?v=TFevZhMs8PU

III: Bloodborn Pathogens

https://www.youtube.com/watch?v=wjpbeqDKZnE
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A message from Dr. Randy Curry
Greetings Pharmacists,
As Electronic Health Records are becoming more numerous at the pharmacy level, it is encouraging to see an
increase of clinical services at the pharmacy level. From Medication Therapy Management, Diabetes SelfEducation Management (DSME), Diabetes Prevention Program (DPP), Point of Care Testing and
immunizations are set to change the face of pharmacy. All of these programs are directed at providing valuebased care. As you implement clinical services, these improve the patients’ outcomes. When their numbers
improve, their health improves, and healthcare cost go down.
From the pharmacy side, all of these programs have the ability to provide the pharmacy with income and thus
making them sustainable.
To help you implement, we encourage you to simply start by checking the blood pressure of your high-risk
patients and logging it. Many diabetes patients are told to keep a blood glucose log. Patients have said
physicians say keep the log, but no one looks at it. This is a great opportunity for pharmacist to step in track
and blood glucose. This opens the door for pharmacist to implement Diabetes Self-Management Education for
the diabetic or Diabetes Prevention Program for the prediabetic.
Below you will find 2017 ACC/AHA Guidelines for Treating Hypertension in Adults Included in 2019 Update.
The first part gives you the diagnostic and treatment algorithm. The second gives you talking points on the
Nonpharmacological therapy.
I have included more specific information on Diabetes Self-Management Education Services and Diabetes
Prevention Program. We have clinical pharmacist on staff that can help you start up these programs for your
patients.
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2020 Metabolic Syndrome Webinar Series

• 4- one hour on-demand webinars
• CE approved by the Oklahoma State Board of Pharmacy
• Webinar topics: hypertension, dyslipidemias, obesity/
impaired fasting glucose, and cardiovascular risk reduction

Sponsored by:

Funding provided by:

2017 ACC/AHA Updated Guidelines for Treating Hypertension in Adults
New guidelines divide blood pressure (BP) levels into 4 categories for diagnosis:

BP Category
Normal
Elevated
Hypertension
Stage 1
Stage 2



Systolic BP (SBP)
<120 mm Hg
120-129 mm Hg

Diastolic BP (DBP)
and <80 mm Hg
and <80 mm Hg

130-139 mm Hg
>140 mm Hg

or
or

80-89 mm Hg
>90 mm Hg

Individuals with SBP and DBP in 2 categories should be placed in higher BP category
BP category determined by using an average of >2 readings obtained on > 2 occasions

Lifestyle interventions have been shown to be effective in significantly facilitating blood pressure lowering.
Weight loss
DASH diet
Potassium intake
Physical activity
Alcohol
consumption
Sodium intake
Tobacco use

Intervention
1 mm Hg per 1 kg lost
Diet rich in vegetables, fruits, whole
grains and low- fat dairy
Goal 3500-5000 mg/day
150 minutes per week
Limit to 2 drinks per day for men and
1 drink per day for women
Goal < 1500 mg/day
Cessation

Reduction of SBP
5 mm Hg
11 mm Hg
5 mm Hg
5-8 mm Hg
4 mm Hg
6 mm Hg
Reduces cardiovascular risk

Treatment Guidelines for Hypertension
Category
Elevated BP
Stage 1 Hypertensionwith clinical ASCVD risk <10%
Stage 1 Hypertensionwith clinical ASCVD risk > 10%
Stage 2 Hypertension

Treatment
Lifestyle interventions
Lifestyle interventions

Follow-up
3-6 months
3-6 months

Lifestyle interventions and BP-lowering
medication
Lifestyle interventions and BP-lowering
medication

1 month
1 month

Recommended blood pressure goal for all patients with hypertension is 130/80 mm Hg.
First-line agents for initial medication use include: thiazide diuretics, CCBs*, ACE inhibitors, or ARBs*.
*CCB- Calcium channel blockers, ARB- Angiotensin II receptor blocker
All information is referenced by:
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ,
Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in
adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;

What is the SWOSU College of Pharmacy Rural Health Center Diabetes Prevention Program?
We are part of the National Diabetes Prevention Program (NDPP), led by the Centers for Disease Control
and Prevention (CDC). This proven program with over ten years of research can help people at risk for
type 2 diabetes make achievable and realistic lifestyle changes and reduce their risk of developing type 2
diabetes. It is a 12 month program with 16 initial weekly sessions and six monthly follow-up sessions
led by trained lifestyle coaches who empower participants to take charge of their health.
Why provide the Diabetes Prevention Program?
Prediabetes is a growing issue with serious health and cost consequences.
•

An estimated 84.1 million Americans and over one million Oklahomans have prediabetes
(1 out of 3 American adults), making them at greater risk for developing type 2 diabetes, heart
disease, and stroke1, 6.

•

In 2012, medical costs and productivity loss due to diabetes were estimated to be $245 billion,
an increase of 41 percent from data collected just five years earlier2.

The program works and is cost-effective.
•

Research examining the results of a structured lifestyle change program found that individuals
with prediabetes reduced their risk of developing type 2 diabetes by 58 percent through proper
diet, exercise, weight loss and behavior modification. Metformin proved to be less effective by
only reducing the risk by 31 percent3.

•

After 10 years, those who had participated in the lifestyle change program had a 34 percent
lower rate of type 2 diabetes compared to 18 percent with Metformin intervention4.

•

In 2013, health care spending per person with diabetes was found to be $14,999 while spending
per individual without diabetes was $4,3055.

•

Effective April 1, 2018, Medicare adopted the Diabetes Prevention Program and made the
Medicare Diabetes Prevention Program (MDPP) available to all eligible Medicare beneficiaries.
MDPP suppliers receive performance based payments through the CMS claims system.

Diabetes Self-Management Education Services
What is Diabetes Self-Management Education?
It is a collaborative process that helps people with diabetes learn how to successfully manage their disease.
The goal of the sessions is to facilitate knowledge and skill for diabetes self-care. This evidence-based program
provides an individualized curriculum for each participant’s needs, goals, and life experiences to improve
health outcomes. It is an ongoing program consisting of core sessions that include but are not limited to:
•

diabetes disease and process, nutritional management, safe medication use, monitoring blood
glucose, preventing, identifying, and treating complications, developing strategies to address
psychosocial issues and promote behavior change, and incorporating physical activity into lifestyle

Why start this service at your pharmacy?
•
•
•
•
•

It has been shown to reduce complications, lower hemoglobin A1c, and lower hospitalizations
It is reimbursable by Medicare and private insurance companies upon recognition/accreditation
Expand clinical services in your community
Collaborate with local health care providers
Empower your patients to manage their diabetes and improve health outcomes

What you can do
Become recognized or accredited through the American Association of Diabetes Educators (AADE)
www.diabeteseducator.org or the American Diabetes Association (ADA)
www.professional.diabetes.org/diabetes-education .

Continuing Education Webinar: “ Implementing Diabetes Self-Management Education and
Support Services in a Community Pharmacy”
When: Please register for Implementing Diabetes Self-management Education Services in a
Community Pharmacy – on-demand webinar
https://attendee.gotowebinar.com/register/6825901631280943371
After registering, you will receive a confirmation email containing information about joining the
webinar.
Offered by: Aimee Henderson, PharmD, BC-ADM, CDE and Travis Wolff, PharmD, BCACP
To learn more, contact:
Aimee Henderson, Pharm. D., BC-ADM, CDE
Office: 580-774-6727
aimee.henderson@swosu.edu

Medicare payments to suppliers will vary, and can be up to $670 per beneficiary over 2 years,
depending on beneficiaries’ attendance and weight loss.
What You Can Do
•

Talk to your health insurance carrier(s) about covering the SWOSU College of Pharmacy Rural
Health Center Diabetes Prevention Program as a health benefit or wellness incentive and offer
this life-changing program to your employees.

•

Third-party administrators can help you determine potential ROI specific to your organization, as
well as help implement the program, process claims, recruit participants, and collect data.
Example calculator: https://ama-roi-calculator.appspot.com/

•

Promote the SWOSU College of Pharmacy Rural Health Center Diabetes Prevention Program to
your employees. We are available 8:00 am to 4:30 pm for questions; we can give out additional
resources about the program, and provide various forms of testing to determine risk for
diabetes.
To learn more, visit www.cdc.gov/diabetes/prevention or contact:
SWOSU College of Pharmacy Rural Health Center
Diabetes Prevention Program
Sarah Yount, Pharm. D.
Office: 580-774-6042
sarah.yount@swosu.edu
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